These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 21624329

  • 1. [Effects of soybean isoflavone on liver lipid metabolism in nonalcoholic fatty liver rats].
    Leng L, Jiang ZQ, Ji GY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Apr; 45(4):335-9. PubMed ID: 21624329
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W.
    Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
    Zhang J, Tan Y, Yao F, Zhang Q.
    Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Isoflavone-poor soy protein alters the lipid metabolism of rats by SREBP-mediated down-regulation of hepatic genes.
    Shukla A, Brandsch C, Bettzieche A, Hirche F, Stangl GI, Eder K.
    J Nutr Biochem; 2007 May; 18(5):313-21. PubMed ID: 16962760
    [Abstract] [Full Text] [Related]

  • 7. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, Fantozzi R, Danni O, Boccuzzi G.
    Free Radic Biol Med; 2009 Oct 01; 47(7):1067-74. PubMed ID: 19616615
    [Abstract] [Full Text] [Related]

  • 8. Effects of soy protein and isoflavone on hepatic fatty acid synthesis and oxidation and mRNA expression of uncoupling proteins and peroxisome proliferator-activated receptor gamma in adipose tissues of rats.
    Takahashi Y, Ide T.
    J Nutr Biochem; 2008 Oct 01; 19(10):682-93. PubMed ID: 18328687
    [Abstract] [Full Text] [Related]

  • 9. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY, Pan JQ, Lv JH.
    Zhongguo Zhong Yao Za Zhi; 2008 Oct 01; 33(20):2385-90. PubMed ID: 19157135
    [Abstract] [Full Text] [Related]

  • 10. Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver.
    Paquette A, Wang D, Jankowski M, Gutkowska J, Lavoie JM.
    Menopause; 2008 Oct 01; 15(6):1169-75. PubMed ID: 18665039
    [Abstract] [Full Text] [Related]

  • 11. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M, Masaki T, Seike M, Yoshimatsu H.
    Exp Biol Med (Maywood); 2007 May 01; 232(5):614-21. PubMed ID: 17463157
    [Abstract] [Full Text] [Related]

  • 12. Melatonin alleviates lipopolysaccharide-induced hepatic SREBP-1c activation and lipid accumulation in mice.
    Chen X, Zhang C, Zhao M, Shi CE, Zhu RM, Wang H, Zhao H, Wei W, Li JB, Xu DX.
    J Pineal Res; 2011 Nov 01; 51(4):416-25. PubMed ID: 21689150
    [Abstract] [Full Text] [Related]

  • 13. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
    Yin J, Luo Y, Deng H, Qin S, Tang W, Zeng L, Zhou B.
    J Ethnopharmacol; 2014 May 28; 154(1):229-39. PubMed ID: 24735863
    [Abstract] [Full Text] [Related]

  • 14. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R, Zhang J, Li C, Zhang X, Xiong A, Huang F, Yin Z, Li K, Qin W, Chen M, Zhang S, Liang L, Zhang H, Nie H, Ye W.
    Arch Pharm Res; 2012 Jul 28; 35(7):1241-50. PubMed ID: 22864747
    [Abstract] [Full Text] [Related]

  • 15. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 28; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 16. Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease.
    Oliveira LP, de Jesús RP, Freire TO, Oliveira CP, Castro Lyra A, Lyra LG.
    Nutr Hosp; 2012 Sep 28; 27(4):991-8. PubMed ID: 23165534
    [Abstract] [Full Text] [Related]

  • 17. Dietary lupin protein lowers triglyceride concentrations in liver and plasma in rats by reducing hepatic gene expression of sterol regulatory element-binding protein-1c.
    Spielmann J, Shukla A, Brandsch C, Hirche F, Stangl GI, Eder K.
    Ann Nutr Metab; 2007 Sep 28; 51(4):387-92. PubMed ID: 17785965
    [Abstract] [Full Text] [Related]

  • 18. Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat.
    Simmen FA, Mercado CP, Zavacki AM, Huang SA, Greenway AD, Kang P, Bowman MT, Prior RL.
    J Nutr Biochem; 2010 Nov 28; 21(11):1106-13. PubMed ID: 19962299
    [Abstract] [Full Text] [Related]

  • 19. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling.
    Hu XQ, Wang YM, Wang JF, Xue Y, Li ZJ, Nagao K, Yanagita T, Xue CH.
    Lipids Health Dis; 2010 Mar 09; 9():25. PubMed ID: 20211032
    [Abstract] [Full Text] [Related]

  • 20. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
    Liu H, Zhong H, Yin Y, Jiang Z.
    Biomed Pharmacother; 2017 Jul 09; 91():964-969. PubMed ID: 28514835
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.